UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 5, 2007
-------------------------------
POSSIS MEDICAL, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Minnesota 0-944 41-0783184
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
9055 Evergreen Boulevard NW, Minneapolis, MN 55433-8003
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 763-780-4555
------------------------------
Not Applicable
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 - Regulation FD Disclosure
On February 5, 2007, Possis Medical, Inc., announced that the United States
District Court for Minnesota has dismissed, with prejudice, the consolidated
amended complaint in a shareholder class action lawsuit filed against Possis
Medical and two of its executive officers, entitled "In re Possis Medical, Inc.,
Securities Litigation." A copy of the press release is furnished as Exhibit 99.1
to this Report.
Item 9.01 Financial Statements and Exhibits
[c] Exhibits
99.1 Press Release, dated February 5, 2007, issued by Possis Medical, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Possis Medical, Inc.
- --------------------
(Registrant)
Date: February 5, 2007
----------------
By: /s/ Jules L. Fisher
-------------------
Jules L. Fisher
Vice President, Finance and Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Description
- ----------- -----------
99.1 Press Release, dated February 5, 2007, issued by Possis Medical,
Inc.